Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Wed 20 Apr 2011, 17:23 AIP - Adcock Ingram Holdings Limited - Update on the MCC resolution to
AIP
AIP                                                                             
AIP - Adcock Ingram Holdings Limited - Update on the MCC resolution to          
withdraw Dextropropoxyphene-Containing Medicines from the South African         
market                                                                          
Adcock Ingram Holdings Limited                                                  
(Incorporated in the Republic of South Africa)                                  
Registration number 2007/016236/06                                              
Share code: AIP                                                                 
ISIN: ZAE000123436                                                              
("Adcock Ingram")                                                               
UPDATE ON THE MCC RESOLUTION TO WITHDRAW DEXTROPROPOXYPHENE-CONTAINING          
MEDICINES FROM THE SOUTH AFRICAN MARKET                                         
Adcock Ingram shareholders are referred to the announcements released by        
Adcock Ingram on 10 December 2010 relating to the recommendation by the         
Medicines Control Council of the Department of Health ("MCC") to withdraw       
dextropropoxyphene ("DPP")-containing medicines from the South African          
market.                                                                         
Shareholders were notified that Adcock Ingram would suspend all promotion and   
sales of DPP-containing products pending further interaction with the MCC and   
that Adcock Ingram would work with the MCC to formulate and execute a plan      
going forward to ensure continued safety of South African patients. The MCC     
later requested Adcock to prepare for a discussion with the Council on the      
safety of DPP and measures to be taken by healthcare providers. All the         
relevant documents were submitted to the MCC.                                   
The MCC has considered comments received from Adcock Ingram at a recently       
held meeting and has resolved to withdraw the registration of all DPP-          
containing medicines within three months from the date of the notice, being     
20 April 2011.                                                                  
Shareholders are advised that Adcock Ingram has a right to appeal the           
decision made by the MCC in accordance with section 24 of the Medicines and     
Related Substances Control Act 101 of 1965. The board of directors of Adcock    
Ingram has resolved to exercise that right and accordingly Adcock Ingram        
intends formulating and lodging an appeal with the MCC. Shareholders will be    
informed of further developments as necessary.                                  
For queries please contact:                                                     
Dudu Ndlovu                                                                     
Group Corporate Affairs,                                                        
Investor Relations and Government Relations                                     
Adcock Ingram                                                                   
Tel: +2711 635 0171                                                             
Mobile: +27(0) 71 689 9796                                                      
For Media queries please contact:                                               
Nthabiseng Mofokeng                                                             
Tel:                               011 502 7413                                 
E-mail:                            nmofokeng@brunswick.co.za                    
Cecilia de Almeida                                                              
Tel:                               011 502 7418                                 
E-mail:                            cdelameida@brunswick.co.za                   
Midrand                                                                         
20 April 2011                                                                   
Sponsor                                                                         
Deutsche Securities (SA) (Proprietary) Limited                                  
Date: 20/04/2011 17:23:01 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.                                          
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: